Ingestible Event Marker (IEM)

· Otsuka Pharmaceutical Development & Commercialization, Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Ingestible Event Marker (IEM), covering 2018-08-03 to 2018-08-03. Get the full timeline:

Most recent: Clinical Trial Update: Substudy 'B' of the Accuracy of Ingestible Event Marker (IEM) Detection by the Medical Information Device #1 (MIND1) [Phase 4]

See pricing